Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis (Q42497888)

1 November 2017

Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. (English)

1 reference

1 November 2017

0 references

1 reference

1 reference

Helliner S Vestri

1

1 reference

1 November 2017

Lidia Maianu

series ordinal

2

1 reference

1 November 2017

Douglas R Moellering

series ordinal

3

1 reference

1 November 2017

W Timothy Garvey

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

28 June 2006

1 reference

1 November 2017

Neuropsychopharmacology

1 reference

1 November 2017

32

1 reference

1 November 2017

765-772

1 reference

1 November 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301142

1 November 2017

0 references

cites work

Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Atypical antipsychotic drug use and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Pharmacokinetics and tissue distribution of olanzapine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Atypical antipsychotics and glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Acute Clozapine Overdose: Plasma Concentration and Outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

A simple method to determine fat cell size and number in four mammalian species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Studies on modulation of feeding behavior by atypical antipsychotics in female mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Metabolic consequences of atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes. Chronic ability to increase glycogen synthase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

New insights into sympathetic regulation of glucose and fat metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Receptor mechanisms in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Drug distribution between blood and brain as a determinant of antipsychotic drug effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301142

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301142

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference